Last reviewed · How we verify

NCT04485897

Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring

Status unknown NA Last updated 6 March 2024
What this trial tests

NA trial testing icare HOME device (Icare Oy, Vanda, Finland) in Intraocular Pressure in 25 participants. Status unknown.

Timeline
26 November 2020
Primary endpoint
1 August 2024
1 August 2024

Quick facts

Lead sponsorLuzerner Kantonsspital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment25
Start date26 November 2020
Primary completion1 August 2024
Estimated completion1 August 2024
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Luzerner Kantonsspital — full company profile →

Who can join

18 and older, any sex, with Intraocular Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Glaucoma remains the leading cause of irreversible blindness worldwide. Glaucoma represents a group of diseases that lead to optic nerve damage and corresponding deterioration of the visual field. Elevated intraocular pressure remains the most important risk factor. Interestingly, glaucomatous damage sometimes occurs despite seemingly normal intraocular pressure. Recent studies suggest pressure peaks, which are missed under the current practice of spot intraocular measurements during office hours. In order to detect pressure peaks diurnal measurements are mandatory. Costly in-hospital diurnal measurements are the current standard. The primary study objective is to verify that self-tonometry at home can provide valuable information when looking for pressure peaks in patients with glaucoma.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Intraocular Pressure

Currently open trials in the same condition.

Other Luzerner Kantonsspital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04485897.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing